L3VLUP
ProSign in

LH · ELV in the 13F filings

Two to four stocks side by side among the 95 tracked managers: who lists them, how that has moved, who bought and sold in a quarter, and which managers hold more than one.

LHELV
Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023

Holders over time

Tracked managers listing each stock every quarter, at least, or their combined reported value. A gap is a quarter in which no tracked manager listed it. Click a quarter to compare there.
  • LH
  • ELV
010203040202120222023202420252026
Holders and value by quarter
QuarterLHELV
Q3 2020none listed holders, n.a.30 holders, $15.0bn
Q4 2020none listed holders, n.a.29 holders, $16.7bn
Q1 2021none listed holders, n.a.25 holders, $18.6bn
Q2 2021none listed holders, n.a.30 holders, $19.4bn
Q3 2021none listed holders, n.a.26 holders, $18.5bn
Q4 2021none listed holders, n.a.29 holders, $23.3bn
Q1 2022none listed holders, n.a.31 holders, $23.9bn
Q2 2022none listed holders, n.a.32 holders, $23.3bn
Q3 2022none listed holders, n.a.34 holders, $22.6bn
Q4 2022none listed holders, n.a.34 holders, $25.5bn
Q1 2023none listed holders, n.a.39 holders, $22.5bn
Q2 2023none listed holders, n.a.38 holders, $20.6bn
Q3 2023none listed holders, n.a.34 holders, $19.8bn
Q4 2023none listed holders, n.a.36 holders, $20.3bn
Q1 2024none listed holders, n.a.35 holders, $21.3bn
Q2 202410 holders, $1.0bn33 holders, $22.1bn
Q3 20248 holders, $715m30 holders, $20.2bn
Q4 202410 holders, $1.0bn32 holders, $15.9bn
Q1 20259 holders, $886m28 holders, $17.1bn
Q2 202512 holders, $1.5bn27 holders, $14.8bn
Q3 20259 holders, $1.8bn27 holders, $12.7bn
Q4 20259 holders, $1.5bn25 holders, $17.0bn
Q1 202612 holders, $1.3bn26 holders, $13.6bn
Q2 20268 holders, $762m28 holders, $17.7bn
LH

Labcorp Holdings Inc

New listing

Holders
10
Reported value
$1.0bn
Buyers
10
Sellers
0

Not ranked this quarter: its new positions are allocations in a new listing.

Health care services and research
ELV

Elevance Health Inc Formerly

Holders
33
Reported value
$22.1bn
Buyers
14
Sellers
21

Breadth -7 among 94 comparable managers.

Health care services and researchManaged care

Who holds both, Q2 2024

Among the 35 tracked managers listing any of them. "Only" is about listed positions: a manager may hold the other below its listed range.

Only LH (2)

Caxton Associates LLP, PDT Partners LLC

Only ELV (25)

Arrowstreet Capital LP, Artisan Partners LP, Baillie Gifford & Co, Balyasny Asset Management LLC, Brevan Howard Capital Management LP, D. E. Shaw & Co., D1 Capital Partners LP, Dodge & Cox, Eisler Capital Management Ltd, ExodusPoint Capital Management LP, Fidelity (FMR LLC), First Eagle Investment Management LLC, Glenview Capital Management LLC, Jane Street Group LLC, Man Group PLC, Marshall Wace LLP, Millennium Management LLC, Moore Capital Management LP, Neuberger Berman Group LLC, Point72 Asset Management LP, Ruane Cunniff & Goldfarb LP, T. Rowe Price Associates Inc, Two Sigma Investments LP, Voloridge Investment Management LLC, Winton Group Ltd

How much of the picture this is

A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. Buyers and sellers count comparable managers (those that filed both quarters) by shares, so a rise in value with no rise in shares is the price. Large books are listed to their largest positions. These are 95 tracked managers, not the institutional market.

Back to the 13F Explorer →